Foresee Pharmaceuticals Co., Ltd.
Records under this name other than the patents Foresee Pharmaceuticals Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 18 patents it holds.
Showing 1 to 6 of 6 · Back to Foresee Pharmaceuticals Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,306,082 | Esters of dihydrotetrabenazine Lapsed on the fee record Ended Apr 19, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 19, 2026 | From the USPTO record |
| US 7,179,831 | 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2, 4-dione and analogues as inhibitors of macrophage elastase Term ended Term ended Aug 17, 2025 · From the USPTO record | Term ended | Term ended Aug 17, 2025 | From the USPTO record |
| US 8,206,735 | Pharmaceutical compositions for sustained release delivery of peptides Lapsed on the fee record Ended Jun 26, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 26, 2024 | From the USPTO record |
| US 7,964,219 | Pharmaceutical compositions for controlled release delivery of biologically active compounds Lapsed on the fee record Ended Jun 21, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 21, 2023 | From the USPTO record |
| US 8,840,915 | Pharmaceutical compositions for sustained release delivery of peptides Lapsed on the fee record Ended Sep 23, 2022 · From the USPTO record | Lapsed on the fee record | Ended Sep 23, 2022 | From the USPTO record |
| US 8,586,103 | Non-polymeric compositions for controlled drug delivery Lapsed on the fee record Ended Nov 19, 2021 · From the USPTO record | Lapsed on the fee record | Ended Nov 19, 2021 | From the USPTO record |